Monopar Therapeutics Inc (MNPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MNPR | AZN | AMGN | GILD | GSK |
| Company | Monopar Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 58.37 | 204.20 | 351.70 | 140.96 | 59.28 |
| High | 59.72 | 204.39 | 352.60 | 140.96 | 59.28 |
| Low | 56.61 | 199.49 | 344.21 | 138.06 | 57.47 |
| Latest | 57.91 | 201.21 | 348.22 | 139.77 | 57.81 |
| Change | -0.01 | -3.17 | -2.73 | -0.68 | -1.37 |
| % Change | -0.02% | -1.55% | -0.78% | -0.48% | -2.31% |
| Volume | 145,300 | 1,657,800 | 2,140,000 | 3,790,500 | 3,379,500 |
| 20-Day Average Volume | 186,450 | 1,911,475 | 2,786,240 | 6,075,375 | 4,259,195 |
| Previous Close | 57.92 | 204.38 | 350.95 | 140.45 | 59.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 55.96 | 195.49 | 349.67 | 139.05 | 55.39 |
| 20-Day Raw Stochastic | 73.52% | 75.55% | 51.36% | 59.36% | 78.07% |
| 20-Day Relative Strength | 50.88 | 55.03 | 45.50 | 48.32 | 57.53 |
| Weighted Alpha | +4.10 | +47.39 | +24.37 | +32.95 | +61.83 |
| Today's Opinion | 56% Sell | 88% Buy | 24% Buy | 56% Buy | 88% Buy |
| Previous Opinion | 56% Sell | 88% Buy | 56% Buy | 56% Buy | 88% Buy |
| Last Month's Opinion | 24% Sell | 56% Buy | 88% Buy | 88% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.21% since 04/08/26 | -1.50% since 04/08/26 | -0.45% since 04/08/26 | -1.25% since 04/08/26 | +0.77% since 04/08/26 |
| Low | 54.67 on 04/10/26 | 199.49 on 04/15/26 | 344.21 on 04/15/26 | 137.02 on 04/13/26 | 57.01 on 04/09/26 |
| High | 60.08 on 04/14/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 59.57 on 04/14/26 |
| 1-Month | |||||
| %Chg | -4.06% since 03/13/26 | +5.96% since 03/13/26 | -4.91% since 03/13/26 | -3.60% since 03/13/26 | +8.28% since 03/13/26 |
| Low | 50.47 on 04/07/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 51.54 on 03/20/26 |
| High | 64.86 on 03/17/26 | 207.30 on 04/10/26 | 370.89 on 03/16/26 | 146.71 on 03/17/26 | 59.57 on 04/14/26 |
| 3-Month | |||||
| %Chg | -16.16% since 01/15/26 | +7.04% since 01/15/26 | +5.51% since 01/15/26 | +15.26% since 01/15/26 | +17.69% since 01/15/26 |
| Low | 50.47 on 04/07/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 122.10 on 01/16/26 | 47.62 on 01/20/26 |
| High | 76.13 on 01/23/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| 6-Month | |||||
| %Chg | -35.95% since 10/15/25 | +18.60% since 10/15/25 | +17.12% since 10/15/25 | +18.15% since 10/15/25 | +32.05% since 10/15/25 |
| Low | 50.47 on 04/07/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.85 on 10/24/25 |
| High | 100.50 on 11/24/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 61.69 on 02/18/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 387,540 | 312,058,208 | 187,929,120 | 173,485,616 | 117,439,688 |
| Shares Outstanding, K | 6,692 | 1,550,908 | 539,685 | 1,241,222 | 2,031,477 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 43,077,970,000 |
| Annual Net Income | -13,720,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,537,690,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 11,424,970,000 |
| Last Quarter Net Income | -5,200,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 851,670,000 |
| 60-Month Beta | 1.64 | 0.35 | 0.47 | 0.39 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.61 on 03/27/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 0.68 on 02/04/26 |
| Latest Earnings Date | 05/12/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.470 on 02/20/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 02/20/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.31 | 16.06 | 17.23 | 13.09 |